clinical trial · NCT07367529
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.·phase2·recruiting·n = 465
Advanced Lung CancerTQB6411 for Injection
brief summary
To evaluate the efficacy and safety of TQB6411 for Injection in subjects with advanced lung cancer
started
Feb 26, 2026
primary completion
Dec 1, 2028
completion
Dec 1, 2028
last updated
May 5, 2026
official title
A Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of TQB6411 for Injection in Patients With Advanced Lung Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol